---
$id: https://graph.org.ai/products/commodity/51282916
$type: Product
source: UNSPSC
code: "51282916"
title: "Enrofloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Enrofloxacin

**UNSPSC Code**: 51282916
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C19H22FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3DX3XEK1BN, chemically known as 1,4-dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-3-quinolinecarboxylic acid but generally known as enrofloxacin, which bears US NIH Compound Identifier 71188. European Medicines Agency schedules Enrofloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06550MIG. The term ENROFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). ENROFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule enrofloxacin under HS 29335995 and SITC 51576. As of Q4 2014, ENROFLOXACIN remains the US FDA Preferred Term for this commodity. Enrofloxacin bears US NLM identifiers UMLS ID C0059374 and NCI Concept Code C72660. SMILES: FC1C(N2CCN(CC2)CC)CC2N(C3CC3)CC(C(=O)C2C1)C(=O)O.

